Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.52 USD | +9.70% |
|
+1.98% | +32.51% |
Jun. 21 | BofA Securities Adjusts PTC Therapeutics Price Target to $32 From $25, Maintains Underperform Rating | MT |
Jun. 20 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.51% | 2.8B | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing